Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Cresco Labs (CRLBF) Cash from Operations (2019 - 2025)

Historic Cash from Operations for Cresco Labs (CRLBF) over the last 7 years, with Q3 2025 value amounting to $6.2 million.

  • Cresco Labs' Cash from Operations fell 8751.29% to $6.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $81.7 million, marking a year-over-year decrease of 952.55%. This contributed to the annual value of $132.5 million for FY2024, which is 12621.41% up from last year.
  • Per Cresco Labs' latest filing, its Cash from Operations stood at $6.2 million for Q3 2025, which was down 8751.29% from $29.5 million recorded in Q4 2024.
  • In the past 5 years, Cresco Labs' Cash from Operations ranged from a high of $49.4 million in Q3 2024 and a low of -$3.3 million during Q4 2023
  • Its 5-year average for Cash from Operations is $22.9 million, with a median of $25.6 million in 2022.
  • Its Cash from Operations has fluctuated over the past 5 years, first plummeted by 19091.16% in 2023, then surged by 99324.45% in 2024.
  • Cresco Labs' Cash from Operations (Quarter) stood at $37.7 million in 2021, then tumbled by 90.36% to $3.6 million in 2022, then crashed by 190.91% to -$3.3 million in 2023, then skyrocketed by 993.24% to $29.5 million in 2024, then tumbled by 79.1% to $6.2 million in 2025.
  • Its Cash from Operations was $6.2 million in Q3 2025, compared to $29.5 million in Q4 2024 and $49.4 million in Q3 2024.